Protocol Ledger

NCT03789760 · Phase III · COMPLETED

The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule

Interventional Phase III clinical trial protocol NCT03789760 sponsored by Shineway Pharmaceutical Co in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-04-10 Enrollment: 493 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03789760
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)493 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03789760
Protocol FieldVerified Registry Value
NCT IdentifierNCT03789760
Consolidated Lead SponsorShineway Pharmaceutical Co
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment493 participants (ACTUAL)
Registered Start Date2019-04-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03789760
Hospital Research SiteLocationSite Profile
Affiliated Hospital of Hebei UniversityBaoding, ChinaOpen Hospital Dossier ->
The First Hospital of Hebei Medical UniversityShijiazhuang, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI